Micro Emerging Active

Climb Bio 的 FDA 快速通道指定

New narrative with limited coverage — still forming.

评分
0.5
动能
▲ 1.0
文章
2
来源
1

Sentiment Timeline

Event Timeline

四月 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
四月 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

相关文章

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · 四月 24, 2026
Mixed

时间线

最后更新四月 22, 2026